Dipòsit Digital de Documents de la UAB 50 registres trobats  1 - 10següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
1.
22 p, 1.5 MB Las concepciones de docentes universitarios de ciencias sobre los contenidos / Rivero, Ana (Universidad de Sevilla. Departamento de Didáctica de las Ciencias Experimentales y Sociales) ; Hamed, Soraya (Universidad de Sevilla. Departamento de Didáctica de las Ciencias Experimentales y Sociales) ; Delord, Gabriela (Universidad de Sevilla) ; Porlán Ariza, Rafael (Universidad de Sevilla. Departamento de Didáctica de las Ciencias Experimentales y Sociales)
En este trabajo se analiza la evolución de las concepciones sobre los contenidos de 16 docentes universitarios de ciencias, cuando realizan ciclos de mejora en el aula en un curso de formación. Para ello, se ha utilizado un cuestionario inicial de preguntas abier-tas y un informe final público sobre su práctica docente. [...]
This work analyzes the evolution of content concepts among 16 university science pro-fessors participating in the Classroom Improvement Cycles (CIC) within the scope of a training program. For this, an initial, open-question questionnaire and a public final re-port about their teaching practice were used, together with a qualitative methodology based on the analysis of content for both instruments. [...]

2020 - 10.5565/rev/ensciencias.2845
Enseñanza de las ciencias, Vol. 38 Núm. 3 (2020) , p. 15-35 (Investigaciones Didácticas)  
2.
11 p, 1.6 MB Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1 / Eron, J.J. (University of North Carolina School of Medicine) ; Orkin, C. (Department of HIV Medicine. Royal Free London NHS Foundation Trust) ; Cunningham, D. (Pueblo Family Physicians) ; Pulido, F. (Medicina Interna. Hospital General Universitario de Alicante) ; Post, F. (King's College Hospital NHS Foundation Trust) ; De Wit, S. (Saint-Pierre University Hospital. Université Libre de Bruxelles) ; Lathouwers, E. (Janssen Pharmaceutica NV) ; Hufkens, V. (Janssen Pharmaceutica NV) ; Jezorwski, J. (Janssen Research & Development) ; Petrovic, R. (Janssen Pharmaceutica NV) ; Brown, K. (Janssen Pharmaceutica NV) ; Van Landuyt, E. (Janssen Pharmaceutica NV) ; Opsomer, M. (Janssen Pharmaceutica NV) ; De Wit, S. (Saint-Pierre University Hospital. Université Libre de Bruxelles) ; Florence, E. (Institute of Tropical Medicine) ; Moutschen, M. (Infectious Diseases department. Liège University Hospital) ; Van Wijngaerden, E. (Department of General Internal Medicine. University Hospitals. KU Leuven - University of Leuven) ; Vandekerckhove, L. (Ghent University and Ghent University Hospital) ; Vandercam, B. (AIDS Reference center. Cliniques Universitaires Saint-Luc) ; Brunetta, J. (Maple Leaf Medical Clinic) ; Conway, B. (Vancouver Infectious Diseases Center) ; Klein, M. (Division of Infectious Diseases. Faculty of Medicine. McGill University Health Centre) ; Murphy, D. (Institut national de santé publique du Québec) ; Rachlis, A. (Sunnybrook Health Sciences Centre) ; Shafran, S. (Department of Medicine. University of Alberta) ; Walmsley, S. (University Health Network) ; Ajana, F. (Infectious Diseases Department. Tourcoing Hospital) ; Cotte, L. (Hospices Civils de Lyon. Hôpital de la Croix-Rousse) ; Girardy, P.M. (University Pierre & Marie Curie) ; Katlama, C. (HIV Clinical Research Unit) ; Molina, J.M. (Department of Infectious Diseases. St-Louis Hospital APHP. University of Paris Diderot) ; Poizot-Martin, I. (Clinical Immuno-Hematology Department. Aix-Marseille University. Sainte-Marguerite University Hospital and Inserm U912) ; Raffi, F. (CHU Hôtel Dieu) ; Rey, D. (Le Trait d'Union. HIV-Infection Care Center. Hôpitaux Universitaires de Strasbourg) ; Reynes, J. (Montpellier University Hospital) ; Teicher, E. (Infectious Diseases Department. APHP. Hôpital Bicêtre) ; Yazdanpanah, Y. ; Gasiorowski, J. (Independent Laboratory for Monitoring Infections among Drug Users at the Department of Infectious Diseases. Liver Disease and Acquired Immune Deficiencies. Wroclaw Medical University) ; Halota, W. (Department of Infectious Diseases and Hepatology. Nicolaus Copernicus University) ; Horban, A. (Medical University of Warsaw. Department for Adult's Infectious Diseases) ; Piekarska, A. (Department of Infectious Diseases and Hepatology. Medical University of Lodz) ; Witor, A. (Regional Hospital. Out-Patient's Clinic for Immune Deficiency) ; Arribas, J.R. (Hospital Universitario La Paz. IdiPAZ) ; Perez-Valero, I. (Department of La Paz Hospital) ; Berenguer, J. (Hospital General Universitario Gregorio Marañón) ; Casado, J. (Department of Infectious Diseases. Ramon y Cajal Hospital) ; Gatell, J.M. (Infectious Diseases Department. HCB) ; Gutiérrez, Félix (Infectious Diseases Unit. Hospital Universitario de Elche) ; Galindo, M.J. (Hospital Clínico Universitario de Valencia) ; Gutiérrez Macià, Mª Del Mar (Institut d'Investigació Biomèdica Sant Pau) ; Iribarren, J.A. (Hospital Universitario Donostia) ; Knobel, H. (Hospital del Mar (Barcelona)) ; Negredo Puigmal, Eugènia. (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Pineda, J.A. (Unit of Infectious Diseases and Microbiology. Hospital Universitario de Valme) ; Podzamczer, D. (dIDIBELL-Hospital Universitari de Bellvitge. L'Hospitalet) ; Sogorb, J.P. (HIV Unit. Hospital 12 de Octubre. imas12. UCM) ; Pulido, F. (Medicina Interna. Hospital General Universitario de Alicante) ; Ricart, C. (Department of Microbiology. School of Medicine. University of Valencia) ; Rivero, A. (Infectious Diseases Unit. Hospital Universitario Reina Sofía. Instituto Maimonides de Investigación Biomedica de Córdoba IMIBIC Cordoba University) ; Santos Gil, I. (Unidad de Enfermedades Infecciosas. Hospital Universitario de la Princesa) ; Blaxhult, A. (Department of Infectious Diseases. Venhälsan. Södersjukhuset) ; Flamholc, L. (Department of Infectious Diseases. Malmö University Hospital) ; Gisslèn, M. (Department of Infectious Diseases. University of Gothenburg) ; Thalme, A. (Department of Infectious Diseases. Karolinska University Hospital) ; Fehr, J. (Division of Infectious Diseases and Hospital Epidemiology. University Hospital Zurich) ; Rauch, A. (Department of Infectious Diseases. Bern University Hospital Inselspital. University of Bern) ; Stoeckle, M. (Division of Infectious Diseases and Hospital Epidemiology. Departments of Medicine and Clinical Research. University Hospital of Basel and University of Basel) ; Clarke, A. (Claude Nicol Centre. Royal Sussex County Hospital. Brighton and Sussex University Hospitals NHS Trust) ; Gazzard, B.G. (St. Stephen's Centre. Department of HIV/Genito-Urinary Medicine. Chelsea and Westminster Hospital) ; Johnson, M.A. (Queen Mary University) ; Orkin, C. (Department of HIV Medicine. Royal Free London NHS Foundation Trust) ; Post, F. (King's College Hospital NHS Foundation Trust) ; Ustianowski, A. (Regional Infectious Diseases Unit. North Manchester General Hospital) ; Waters, L. (University College London Hospital) ; Bailey, J. (Department of Medicine. Johns Hopkins University School of Medicine) ; Benson, P. (Be Well Medical) ; Bhatti, L. (AIDS Healthcare Foundation) ; Brar, I. (Henry Ford Hospital) ; Bredeek, U.F. (Metropolis Medical PC) ; Brinson, C. (Central Texas Clinical Research) ; Crofoot, G. (The Crofoot Research Center) ; Cunningham, D. (Pueblo Family Physicians) ; DeJesus, E. (Pueblo Family Physicians) ; Dietz, C. (Orlando Immunology Center) ; Dretler, R. (HIV Medicine. Kansas City Free Health Clinic) ; Eron, J. (Infectious Disease Specialists of Atlanta) ; Felizarta, F. (Private Practice) ; Fichtenbaum, C. (University of Cincinnati College of Medicine) ; Gallant, J. (Southwest CARE Center) ; Gathe, J. (Therapeutic Concepts) ; Hagins, D. (Georgia Department of Public Health. Chatham Care Center) ; Henn, S. (Whitman-Walker Health) ; Henry, W.K. (Department of Medicine. University of Minnesota Washington University School of Medicine) ; Huhn, G. (Ruth M. Rothstein CORE Center) ; Jain, M. (Department of Internal Medicine. University of Texas Southwestern Medical Center) ; Lucasti, C. (South Jersey Infectious Disease) ; Martorell, C. (Infectious Disease and The Research Institute) ; McDonald, C. (Tarrant County Infectious Disease Associates) ; Mills, A. (Southern California Men's Medical Group) ; Morales-Ramirez, J. (Clinical Research Puerto Rico Inc.) ; Mounzer, K. (Philadelphia FIGHT) ; Nahass, R. (ID Care) ; Olivet, H. (Community Research Initiative of New England) ; Osiyemi, O. (Triple O Research Institute PA) ; Prelutsky, D. (Department of Internal Medicine. Washington University School of Medicine) ; Ramgopal, M. (Midway Immunology Center. Fort Pierce) ; Rashbaum, B. (Capital Medical Associates) ; Richmond, G. (Broward General Medical Center) ; Ruane, P. (Ruane Clinical Research Group) ; Scarsella, A. (Pacific Oaks Medical Group) ; Scribner, A. (DCOL Center for Clinical Research) ; Shalit, P. (Peter Shalit MD and Associates) ; Shamblaw, D. (La Playa Medical Group) ; Slim, J. (Department of Infectious Diseases. Seton Hall University) ; Tashima, K. (The Miriam Hospital. Warren Alpert Medical School of Brown University) ; Voskuhl, G. (AIDS Arms. Inc.) ; Ward, D. (Dupont Circle Physicians Group) ; Wilkin, A. (Wake Forest School of Medicine) ; de Vente, J. (Living Hope Foundation) ; Universitat Autònoma de Barcelona
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. [...]
2019 - 10.1016/j.antiviral.2019.104543
Antiviral Research, Vol. 170 (october 2019) , p. 104543  
3.
3 p, 312.2 KB Tecnologia dels Mitjans Audio-visuals en publi. (TV i Cinema) [20677] / Rivero Sánchez, José A. ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
2001-02
Llicenciat en Publicitat i Relacions Públiques [66]  
4.
4 p, 376.9 KB Teoria i Tècnica de la Fotografia [20659] / Rivero Sánchez, José A. ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
2001-02
Llicenciat en Publicitat i Relacions Públiques [66]  
5.
2 p, 206.2 KB Tecnologia Audio-Visual en Publicitat. (Fotografia Publicit.) [20652] / Rivero Sánchez, José A. ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
2001-02
Llicenciat en Publicitat i Relacions Públiques [66]  
6.
5 p, 1.8 MB Teoria i Tècnica de la Fotografia [20659] / Rivero, José Antonio ; Bertran, Eduard ; Hernández, Juan Bautista ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
2003-04
Grau en Comunicació Audiovisual [968]
Grau en Publicitat i Relacions Públiques [972]
2 documents
7.
5 p, 671.4 KB Tecnologia dels Mitjans Audio-visuals en publi. (TV i Cinema) [20677] / Rivero, José Antonio ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
2003-04
Grau en Publicitat i Relacions Públiques [972]  
8.
4 p, 502.4 KB Tecnologia Audio-Visual en Publicitat. (Fotografia Publicit.) [20652] / Rivero, José Antonio ; Universitat Autònoma de Barcelona. Facultat de Ciències de la Comunicació
2003-04
Grau en Publicitat i Relacions Públiques [972]  
9.
12 p, 1.4 MB Aplicació autònoma de Picking per veu utilitzant tecnologia MCL-Voice / Vergara Rivero, Adrián ; Gil Resina, Debora, dir. (Universitat Autònoma de Barcelona. Departament de Ciències de la Computació) ; Universitat Autònoma de Barcelona. Escola d'Enginyeria
El picking és una activitat de preparació de comandes que consisteix en la recollida i combinació de paquets per confirmar la comanda d'un client. Aquest procés es duu a terme en els magatzems de les empreses que es dediquen a oferir serveis logístics dins la cadena de subministrament. [...]
El picking es una actividad de preparación de pedidos que consiste en la recogida y combinación de paquetes para confirmar el pedido de un cliente. Este proceso se lleva a cabo en los almacenes de las empresas que se dedican a ofrecer servicios logísticos dentro de la cadena de suministro. [...]
Picking is an order preparation activity that consists in pick up and combine parcels to confirm a client order. This process is carried out in company's warehouses that are dedicated to providing logistics services of the supply chain. [...]

2018-06-30
Enginyeria Informàtica [958]  
10.
10 p, 834.6 KB Health services research in patients with breast cancer (CAMISS-prospective) : study protocol for an observational prospective study / García-Gutierrez, Susana (Galdakao-Usansolo Hospital - Red de Investigación en Servicios de Salud en Enfermedades Crónicas [REDISSEC]) ; Orive, Miren (Galdakao-Usansolo Hospital - Red de Investigación en Servicios de Salud en Enfermedades Crónicas [REDISSEC]) ; Sarasqueta, Cristina (Hospital Universitario Donostia - Red de Investigación en Servicios de Salud en Enfermedades Crónicas [REDISSEC]) ; Legarreta, Maria Jose (Universidad del País Vasco) ; Gonzalez, Nerea (Galdakao-Usansolo Hospital - Red de Investigación en Servicios de Salud en Enfermedades Crónicas [REDISSEC]) ; Redondo, Maximino (Agencia Sanitaria Costa del Sol) ; Rivero, Amado (Fundación Canaria de Investigación y Salud) ; Serrano-Aguilar, Pedro (Servicio Canario de la Salud) ; Castells, Xavier (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Quintana, Jose Maria (Galdakao-Usansolo Hospital - Red de Investigación en Servicios de Salud en Enfermedades Crónicas [REDISSEC]) ; Sala, Maria (Institut Hospital del Mar d'Investigacions Mèdiques)
Though breast cancer remains a major health problem, there is a lack of information on health care provided to patients with this disease and associated costs. In addition, there is a need to update and validate risk stratification tools in Spain. [...]
2018 - 10.1186/s12885-017-3926-9
BMC Cancer, Vol. 18 (january 2018)  

Dipòsit Digital de Documents de la UAB : 50 registres trobats   1 - 10següentfinal  anar al registre:
Vegeu també: autors amb noms similars
1 Rivero, Amado
3 Rivero, Ana
2 Rivero, Angel
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.